Dermatology Drug Trials Drugs Research 
Drug Discovery World
NOVEMBER 30, 2023
The US Food and Drug Administration (FDA) recently granted Orphan Drug Designation for FT011 for the treatment of systemic sclerosis (scleroderma). The post Scleroderma drug trial shows up to 60% improvement appeared first on Drug Discovery World (DDW).
pharmaphorum
MAY 14, 2021
China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. Reuters quoted Kintor’s chief financial officer Lucy Lu, who said that Kayali was one of its trial investigators.
STAT News
DECEMBER 2, 2022
And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies. And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies.
Expert insights. Personalized for you.
59 
Let's personalize your content